APA

Katagiri S., Makishima H., Azuma K., Nannya Y., Saitoh Y., Yoshizawa S., Akahane D., Fujimoto H., Ito Y., Velaga R., Umezu T., Ohyashiki J. H., Ogawa S. & Ohyashiki K. (20210427). Predisposed genomic instability in pre-treatment bone marrow evolves to therapy-related myeloid neoplasms in malignant lymphoma. : Haematologica.

Chicago

Katagiri Seiichiro, Makishima Hideki, Azuma Kenko, Nannya Yasuhito, Saitoh Yuu, Yoshizawa Seiichiro, Akahane Daigo, Fujimoto Hiroaki, Ito Yoshikazu, Velaga Ravi, Umezu Tomohiro, Ohyashiki Junko H, Ogawa Seishi and Ohyashiki Kazuma. 20210427. Predisposed genomic instability in pre-treatment bone marrow evolves to therapy-related myeloid neoplasms in malignant lymphoma. : Haematologica.

Harvard

Katagiri S., Makishima H., Azuma K., Nannya Y., Saitoh Y., Yoshizawa S., Akahane D., Fujimoto H., Ito Y., Velaga R., Umezu T., Ohyashiki J. H., Ogawa S. and Ohyashiki K. (20210427). Predisposed genomic instability in pre-treatment bone marrow evolves to therapy-related myeloid neoplasms in malignant lymphoma. : Haematologica.

MLA

Katagiri Seiichiro, Makishima Hideki, Azuma Kenko, Nannya Yasuhito, Saitoh Yuu, Yoshizawa Seiichiro, Akahane Daigo, Fujimoto Hiroaki, Ito Yoshikazu, Velaga Ravi, Umezu Tomohiro, Ohyashiki Junko H, Ogawa Seishi and Ohyashiki Kazuma. Predisposed genomic instability in pre-treatment bone marrow evolves to therapy-related myeloid neoplasms in malignant lymphoma. : Haematologica. 20210427.